Full Text View
Tabular View
No Study Results Posted
Related Studies
A Clinical Trial on the Antipsychotic Properties of Cannabidiol
This study has been completed.
Study NCT00309413   Information provided by University of Cologne

First Received on March 30, 2006.   Last Updated on July 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Psychotic Disorders
Additional conditions recognized in this trial
Mental Disorders
More general conditions related to this trial
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Placebo/Cannabidiol
Cannabidiol/Placebo
Additional drug interventions recognized in this trial
Antipsychotic Agents
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
University of Cologne
Stanley Medical Research Institute
Coordinating Centre for Clinical Trials Cologne


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services